The conclusion of a comparative efficacy study of fluralaner and sarolaner against the tick Amblyomma americanum on dogs is based on results obtained at study times that are outside the fluralaner label recommendations [PDF]
Rob Armstrong
core +3 more sources
The effect of water and shampooing on the efficacy of fluralaner spot-on solution against and infestations in dogs [PDF]
Janina Taenzler+4 more
core +3 more sources
Effectiveness of transdermal fluralaner in the treatment of Lynxacarus radovskyi (Acari: Listrophoridae) in naturally infested domestic cats. [PDF]
Guimarães BMC+6 more
europepmc +3 more sources
The mosquitocidal activity of isoxazoline derivatives afoxolaner, lotilaner, and fluralaner are not affected by mosquito sugar or antibiotic treatment. [PDF]
Soré H+8 more
europepmc +3 more sources
Open field study on the efficacy of oral fluralaner for long-term control of flea allergy dermatitis in client-owned dogs in Ile-de-France region [PDF]
BACKGROUND: Fluralaner is the first orally administered isoxazoline to provide 12 weeks of activity against fleas and ticks after a single administration.
Céline Hubinois+5 more
core +4 more sources
Evaluation of the scabicidal effect of a single dose of fluralaner in a rabbit model of crusted scabies. [PDF]
Sharaf MS+4 more
europepmc +3 more sources
Acaricidal efficacy of fluralaner against Rhipicephalus microplus ticks under laboratory and field conditions in Brazil. [PDF]
Rodrigues DC+13 more
europepmc +2 more sources
Flea and tick treatment satisfaction, preference, and adherence of U.S. cat owners prescribed topical fluralaner (Bravecto® Topical Solution for Cats) [PDF]
Background: Fluralaner is a novel isoxazoline compound and the only systemically distributed ectoparasiticide approved in the United States for re-dosing at up to 12-week intervals for flea and tick control in cats.
Robert Lavan+3 more
doaj +1 more source
Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the U.S., U.K., or France who treated their cats with transdermal fluralaner [PDF]
Background: Fluralaner (Bravecto®) is an isoxazoline class compound that is the only topically applied systemic ectoparasiticide approved for dosing at up to 12-week intervals for flea and tick control in cats.
Robert Philip Lavan+4 more
doaj +1 more source
Correction: Fluralaner systemic treatment of chickens results in mortality in Triatoma gerstaeckeri, vector of the agent of Chagas disease. [PDF]
Durden C+7 more
europepmc +2 more sources